Global (United States, European Union and China) Methyltestosterone
Global (United States, European Union and China) Methyltestosterone

Methyltestosterone Comprehensive Study by Type (Capsules, Tablets, Powder), Application (Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others}, Non-Medical), End Users (Males, Females) Players and Region - Global Market Outlook to 2024

Methyltestosterone Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Aug 2019 Edition 205 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Methyltestosterone Market Overview:
Methyltestosterone is sold under the brand names such as Metandren, Android, and Testred among others. It is an anabolic steroid (AAS) and androgen medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, at low doses as a component of menopausal hormone therapy for menopausal symptoms like hot flashes, osteoporosis, and low sexual desire in women. Moreover, it is also used in women to treat breast cancer that has spread to other parts of the body. It is taken by mouth.

Market Drivers
  • The Increase in Prevalence of Delayed Puberty
  • The Rise in Demand for Methyltestosterone from Physique- And Performance-Enhancing Purposes
  • The Surging Prevalence of Erectile Dysfunction (ED) In Young Men


Restraints
  • Side Effects Associated with its Consumption

Opportunities
  • The Growth Opportunities from Developing Countries


Competitive Landscape:

Some of the key players profiled in the report are Impax Laboratories (United States), Bausch Health (Canada), HARBIN PHARMACEUTICAL GROUP (China), Centrix Pharmaceutical, Inc. (United States), Conscientia Industrial Co., Ltd (Hong Kong), Farmabios SpA (Italy) and AASraw Biochemical Technology Co.; Ltd (Hong Kong). Analyst at AdvanceMarketAnalytics see United States and Hong Kong Players to retain maximum share of Global Methyltestosterone market by 2024. Considering Market by End Users, the sub-segment i.e. Males will boost the Methyltestosterone market.

Market Highlights:

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Methyltestosterone market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Methyltestosterone market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Methyltestosterone Manufacturers, Methyltestosterone Traders/Distributors, Methyltestosterone Importer/Exporter, Research & Consulting Firms, Regulatory & Government Bodies, Research Institutes, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Capsules
  • Tablets
  • Powder
By Application
  • Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others}
  • Non-Medical
By End Users
  • Males
  • Females

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Increase in Prevalence of Delayed Puberty
      • 3.2.2. The Rise in Demand for Methyltestosterone from Physique- And Performance-Enhancing Purposes
      • 3.2.3. The Surging Prevalence of Erectile Dysfunction (ED) In Young Men
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Methyltestosterone, by Type, Application, End Users and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Methyltestosterone (Value)
      • 5.2.1. Global Methyltestosterone by: Type (Value)
        • 5.2.1.1. Capsules
        • 5.2.1.2. Tablets
        • 5.2.1.3. Powder
      • 5.2.2. Global Methyltestosterone by: Application (Value)
        • 5.2.2.1. Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others}
        • 5.2.2.2. Non-Medical
      • 5.2.3. Global Methyltestosterone by: End Users (Value)
        • 5.2.3.1. Males
        • 5.2.3.2. Females
      • 5.2.4. Global Methyltestosterone Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Methyltestosterone (Volume)
      • 5.3.1. Global Methyltestosterone by: Type (Volume)
        • 5.3.1.1. Capsules
        • 5.3.1.2. Tablets
        • 5.3.1.3. Powder
      • 5.3.2. Global Methyltestosterone by: Application (Volume)
        • 5.3.2.1. Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others}
        • 5.3.2.2. Non-Medical
      • 5.3.3. Global Methyltestosterone by: End Users (Volume)
        • 5.3.3.1. Males
        • 5.3.3.2. Females
      • 5.3.4. Global Methyltestosterone Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Methyltestosterone (Price)
      • 5.4.1. Global Methyltestosterone by: Type (Price)
  • 6. Methyltestosterone: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Impax Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bausch Health (Canada)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. HARBIN PHARMACEUTICAL GROUP (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Centrix Pharmaceutical, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Conscientia Industrial Co., Ltd (Hong Kong)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Farmabios SpA (Italy)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. AASraw Biochemical Technology Co.; Ltd (Hong Kong)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Methyltestosterone Sale, by Type, Application, End Users and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Methyltestosterone (Value)
      • 7.2.1. Global Methyltestosterone by: Type (Value)
        • 7.2.1.1. Capsules
        • 7.2.1.2. Tablets
        • 7.2.1.3. Powder
      • 7.2.2. Global Methyltestosterone by: Application (Value)
        • 7.2.2.1. Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others}
        • 7.2.2.2. Non-Medical
      • 7.2.3. Global Methyltestosterone by: End Users (Value)
        • 7.2.3.1. Males
        • 7.2.3.2. Females
      • 7.2.4. Global Methyltestosterone Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Methyltestosterone (Volume)
      • 7.3.1. Global Methyltestosterone by: Type (Volume)
        • 7.3.1.1. Capsules
        • 7.3.1.2. Tablets
        • 7.3.1.3. Powder
      • 7.3.2. Global Methyltestosterone by: Application (Volume)
        • 7.3.2.1. Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others}
        • 7.3.2.2. Non-Medical
      • 7.3.3. Global Methyltestosterone by: End Users (Volume)
        • 7.3.3.1. Males
        • 7.3.3.2. Females
      • 7.3.4. Global Methyltestosterone Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Methyltestosterone (Price)
      • 7.4.1. Global Methyltestosterone by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Methyltestosterone: by Type(USD Million)
  • Table 2. Methyltestosterone Capsules , by Region USD Million (2013-2018)
  • Table 3. Methyltestosterone Tablets , by Region USD Million (2013-2018)
  • Table 4. Methyltestosterone Powder , by Region USD Million (2013-2018)
  • Table 5. Methyltestosterone: by Application(USD Million)
  • Table 6. Methyltestosterone Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others} , by Region USD Million (2013-2018)
  • Table 7. Methyltestosterone Non-Medical , by Region USD Million (2013-2018)
  • Table 8. Methyltestosterone: by End Users(USD Million)
  • Table 9. Methyltestosterone Males , by Region USD Million (2013-2018)
  • Table 10. Methyltestosterone Females , by Region USD Million (2013-2018)
  • Table 11. South America Methyltestosterone, by Country USD Million (2013-2018)
  • Table 12. South America Methyltestosterone, by Type USD Million (2013-2018)
  • Table 13. South America Methyltestosterone, by Application USD Million (2013-2018)
  • Table 14. South America Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 15. Brazil Methyltestosterone, by Type USD Million (2013-2018)
  • Table 16. Brazil Methyltestosterone, by Application USD Million (2013-2018)
  • Table 17. Brazil Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 18. Argentina Methyltestosterone, by Type USD Million (2013-2018)
  • Table 19. Argentina Methyltestosterone, by Application USD Million (2013-2018)
  • Table 20. Argentina Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 21. Rest of South America Methyltestosterone, by Type USD Million (2013-2018)
  • Table 22. Rest of South America Methyltestosterone, by Application USD Million (2013-2018)
  • Table 23. Rest of South America Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 24. Asia Pacific Methyltestosterone, by Country USD Million (2013-2018)
  • Table 25. Asia Pacific Methyltestosterone, by Type USD Million (2013-2018)
  • Table 26. Asia Pacific Methyltestosterone, by Application USD Million (2013-2018)
  • Table 27. Asia Pacific Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 28. China Methyltestosterone, by Type USD Million (2013-2018)
  • Table 29. China Methyltestosterone, by Application USD Million (2013-2018)
  • Table 30. China Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 31. Japan Methyltestosterone, by Type USD Million (2013-2018)
  • Table 32. Japan Methyltestosterone, by Application USD Million (2013-2018)
  • Table 33. Japan Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 34. India Methyltestosterone, by Type USD Million (2013-2018)
  • Table 35. India Methyltestosterone, by Application USD Million (2013-2018)
  • Table 36. India Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 37. South Korea Methyltestosterone, by Type USD Million (2013-2018)
  • Table 38. South Korea Methyltestosterone, by Application USD Million (2013-2018)
  • Table 39. South Korea Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 40. Taiwan Methyltestosterone, by Type USD Million (2013-2018)
  • Table 41. Taiwan Methyltestosterone, by Application USD Million (2013-2018)
  • Table 42. Taiwan Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 43. Australia Methyltestosterone, by Type USD Million (2013-2018)
  • Table 44. Australia Methyltestosterone, by Application USD Million (2013-2018)
  • Table 45. Australia Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 46. Rest of Asia-Pacific Methyltestosterone, by Type USD Million (2013-2018)
  • Table 47. Rest of Asia-Pacific Methyltestosterone, by Application USD Million (2013-2018)
  • Table 48. Rest of Asia-Pacific Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 49. Europe Methyltestosterone, by Country USD Million (2013-2018)
  • Table 50. Europe Methyltestosterone, by Type USD Million (2013-2018)
  • Table 51. Europe Methyltestosterone, by Application USD Million (2013-2018)
  • Table 52. Europe Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 53. Germany Methyltestosterone, by Type USD Million (2013-2018)
  • Table 54. Germany Methyltestosterone, by Application USD Million (2013-2018)
  • Table 55. Germany Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 56. France Methyltestosterone, by Type USD Million (2013-2018)
  • Table 57. France Methyltestosterone, by Application USD Million (2013-2018)
  • Table 58. France Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 59. Italy Methyltestosterone, by Type USD Million (2013-2018)
  • Table 60. Italy Methyltestosterone, by Application USD Million (2013-2018)
  • Table 61. Italy Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 62. United Kingdom Methyltestosterone, by Type USD Million (2013-2018)
  • Table 63. United Kingdom Methyltestosterone, by Application USD Million (2013-2018)
  • Table 64. United Kingdom Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 65. Netherlands Methyltestosterone, by Type USD Million (2013-2018)
  • Table 66. Netherlands Methyltestosterone, by Application USD Million (2013-2018)
  • Table 67. Netherlands Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 68. Rest of Europe Methyltestosterone, by Type USD Million (2013-2018)
  • Table 69. Rest of Europe Methyltestosterone, by Application USD Million (2013-2018)
  • Table 70. Rest of Europe Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 71. MEA Methyltestosterone, by Country USD Million (2013-2018)
  • Table 72. MEA Methyltestosterone, by Type USD Million (2013-2018)
  • Table 73. MEA Methyltestosterone, by Application USD Million (2013-2018)
  • Table 74. MEA Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 75. Middle East Methyltestosterone, by Type USD Million (2013-2018)
  • Table 76. Middle East Methyltestosterone, by Application USD Million (2013-2018)
  • Table 77. Middle East Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 78. Africa Methyltestosterone, by Type USD Million (2013-2018)
  • Table 79. Africa Methyltestosterone, by Application USD Million (2013-2018)
  • Table 80. Africa Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 81. North America Methyltestosterone, by Country USD Million (2013-2018)
  • Table 82. North America Methyltestosterone, by Type USD Million (2013-2018)
  • Table 83. North America Methyltestosterone, by Application USD Million (2013-2018)
  • Table 84. North America Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 85. United States Methyltestosterone, by Type USD Million (2013-2018)
  • Table 86. United States Methyltestosterone, by Application USD Million (2013-2018)
  • Table 87. United States Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 88. Canada Methyltestosterone, by Type USD Million (2013-2018)
  • Table 89. Canada Methyltestosterone, by Application USD Million (2013-2018)
  • Table 90. Canada Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 91. Mexico Methyltestosterone, by Type USD Million (2013-2018)
  • Table 92. Mexico Methyltestosterone, by Application USD Million (2013-2018)
  • Table 93. Mexico Methyltestosterone, by End Users USD Million (2013-2018)
  • Table 94. Methyltestosterone Sales: by Type(K Tons)
  • Table 95. Methyltestosterone Sales Capsules , by Region K Tons (2013-2018)
  • Table 96. Methyltestosterone Sales Tablets , by Region K Tons (2013-2018)
  • Table 97. Methyltestosterone Sales Powder , by Region K Tons (2013-2018)
  • Table 98. Methyltestosterone Sales: by Application(K Tons)
  • Table 99. Methyltestosterone Sales Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others} , by Region K Tons (2013-2018)
  • Table 100. Methyltestosterone Sales Non-Medical , by Region K Tons (2013-2018)
  • Table 101. Methyltestosterone Sales: by End Users(K Tons)
  • Table 102. Methyltestosterone Sales Males , by Region K Tons (2013-2018)
  • Table 103. Methyltestosterone Sales Females , by Region K Tons (2013-2018)
  • Table 104. South America Methyltestosterone Sales, by Country K Tons (2013-2018)
  • Table 105. South America Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 106. South America Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 107. South America Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 108. Brazil Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 109. Brazil Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 110. Brazil Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 111. Argentina Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 112. Argentina Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 113. Argentina Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 114. Rest of South America Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 115. Rest of South America Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 116. Rest of South America Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 117. Asia Pacific Methyltestosterone Sales, by Country K Tons (2013-2018)
  • Table 118. Asia Pacific Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 119. Asia Pacific Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 120. Asia Pacific Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 121. China Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 122. China Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 123. China Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 124. Japan Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 125. Japan Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 126. Japan Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 127. India Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 128. India Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 129. India Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 130. South Korea Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 131. South Korea Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 132. South Korea Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 133. Taiwan Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 134. Taiwan Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 135. Taiwan Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 136. Australia Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 137. Australia Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 138. Australia Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 139. Rest of Asia-Pacific Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 140. Rest of Asia-Pacific Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 141. Rest of Asia-Pacific Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 142. Europe Methyltestosterone Sales, by Country K Tons (2013-2018)
  • Table 143. Europe Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 144. Europe Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 145. Europe Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 146. Germany Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 147. Germany Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 148. Germany Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 149. France Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 150. France Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 151. France Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 152. Italy Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 153. Italy Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 154. Italy Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 155. United Kingdom Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 156. United Kingdom Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 157. United Kingdom Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 158. Netherlands Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 159. Netherlands Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 160. Netherlands Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 161. Rest of Europe Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 162. Rest of Europe Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 163. Rest of Europe Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 164. MEA Methyltestosterone Sales, by Country K Tons (2013-2018)
  • Table 165. MEA Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 166. MEA Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 167. MEA Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 168. Middle East Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 169. Middle East Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 170. Middle East Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 171. Africa Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 172. Africa Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 173. Africa Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 174. North America Methyltestosterone Sales, by Country K Tons (2013-2018)
  • Table 175. North America Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 176. North America Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 177. North America Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 178. United States Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 179. United States Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 180. United States Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 181. Canada Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 182. Canada Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 183. Canada Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 184. Mexico Methyltestosterone Sales, by Type K Tons (2013-2018)
  • Table 185. Mexico Methyltestosterone Sales, by Application K Tons (2013-2018)
  • Table 186. Mexico Methyltestosterone Sales, by End Users K Tons (2013-2018)
  • Table 187. Methyltestosterone: by Type(USD/Units)
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Methyltestosterone: by Type(USD Million)
  • Table 196. Methyltestosterone Capsules , by Region USD Million (2019-2024)
  • Table 197. Methyltestosterone Tablets , by Region USD Million (2019-2024)
  • Table 198. Methyltestosterone Powder , by Region USD Million (2019-2024)
  • Table 199. Methyltestosterone: by Application(USD Million)
  • Table 200. Methyltestosterone Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others} , by Region USD Million (2019-2024)
  • Table 201. Methyltestosterone Non-Medical , by Region USD Million (2019-2024)
  • Table 202. Methyltestosterone: by End Users(USD Million)
  • Table 203. Methyltestosterone Males , by Region USD Million (2019-2024)
  • Table 204. Methyltestosterone Females , by Region USD Million (2019-2024)
  • Table 205. South America Methyltestosterone, by Country USD Million (2019-2024)
  • Table 206. South America Methyltestosterone, by Type USD Million (2019-2024)
  • Table 207. South America Methyltestosterone, by Application USD Million (2019-2024)
  • Table 208. South America Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 209. Brazil Methyltestosterone, by Type USD Million (2019-2024)
  • Table 210. Brazil Methyltestosterone, by Application USD Million (2019-2024)
  • Table 211. Brazil Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 212. Argentina Methyltestosterone, by Type USD Million (2019-2024)
  • Table 213. Argentina Methyltestosterone, by Application USD Million (2019-2024)
  • Table 214. Argentina Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 215. Rest of South America Methyltestosterone, by Type USD Million (2019-2024)
  • Table 216. Rest of South America Methyltestosterone, by Application USD Million (2019-2024)
  • Table 217. Rest of South America Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 218. Asia Pacific Methyltestosterone, by Country USD Million (2019-2024)
  • Table 219. Asia Pacific Methyltestosterone, by Type USD Million (2019-2024)
  • Table 220. Asia Pacific Methyltestosterone, by Application USD Million (2019-2024)
  • Table 221. Asia Pacific Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 222. China Methyltestosterone, by Type USD Million (2019-2024)
  • Table 223. China Methyltestosterone, by Application USD Million (2019-2024)
  • Table 224. China Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 225. Japan Methyltestosterone, by Type USD Million (2019-2024)
  • Table 226. Japan Methyltestosterone, by Application USD Million (2019-2024)
  • Table 227. Japan Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 228. India Methyltestosterone, by Type USD Million (2019-2024)
  • Table 229. India Methyltestosterone, by Application USD Million (2019-2024)
  • Table 230. India Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 231. South Korea Methyltestosterone, by Type USD Million (2019-2024)
  • Table 232. South Korea Methyltestosterone, by Application USD Million (2019-2024)
  • Table 233. South Korea Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 234. Taiwan Methyltestosterone, by Type USD Million (2019-2024)
  • Table 235. Taiwan Methyltestosterone, by Application USD Million (2019-2024)
  • Table 236. Taiwan Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 237. Australia Methyltestosterone, by Type USD Million (2019-2024)
  • Table 238. Australia Methyltestosterone, by Application USD Million (2019-2024)
  • Table 239. Australia Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 240. Rest of Asia-Pacific Methyltestosterone, by Type USD Million (2019-2024)
  • Table 241. Rest of Asia-Pacific Methyltestosterone, by Application USD Million (2019-2024)
  • Table 242. Rest of Asia-Pacific Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 243. Europe Methyltestosterone, by Country USD Million (2019-2024)
  • Table 244. Europe Methyltestosterone, by Type USD Million (2019-2024)
  • Table 245. Europe Methyltestosterone, by Application USD Million (2019-2024)
  • Table 246. Europe Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 247. Germany Methyltestosterone, by Type USD Million (2019-2024)
  • Table 248. Germany Methyltestosterone, by Application USD Million (2019-2024)
  • Table 249. Germany Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 250. France Methyltestosterone, by Type USD Million (2019-2024)
  • Table 251. France Methyltestosterone, by Application USD Million (2019-2024)
  • Table 252. France Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 253. Italy Methyltestosterone, by Type USD Million (2019-2024)
  • Table 254. Italy Methyltestosterone, by Application USD Million (2019-2024)
  • Table 255. Italy Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 256. United Kingdom Methyltestosterone, by Type USD Million (2019-2024)
  • Table 257. United Kingdom Methyltestosterone, by Application USD Million (2019-2024)
  • Table 258. United Kingdom Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 259. Netherlands Methyltestosterone, by Type USD Million (2019-2024)
  • Table 260. Netherlands Methyltestosterone, by Application USD Million (2019-2024)
  • Table 261. Netherlands Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 262. Rest of Europe Methyltestosterone, by Type USD Million (2019-2024)
  • Table 263. Rest of Europe Methyltestosterone, by Application USD Million (2019-2024)
  • Table 264. Rest of Europe Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 265. MEA Methyltestosterone, by Country USD Million (2019-2024)
  • Table 266. MEA Methyltestosterone, by Type USD Million (2019-2024)
  • Table 267. MEA Methyltestosterone, by Application USD Million (2019-2024)
  • Table 268. MEA Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 269. Middle East Methyltestosterone, by Type USD Million (2019-2024)
  • Table 270. Middle East Methyltestosterone, by Application USD Million (2019-2024)
  • Table 271. Middle East Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 272. Africa Methyltestosterone, by Type USD Million (2019-2024)
  • Table 273. Africa Methyltestosterone, by Application USD Million (2019-2024)
  • Table 274. Africa Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 275. North America Methyltestosterone, by Country USD Million (2019-2024)
  • Table 276. North America Methyltestosterone, by Type USD Million (2019-2024)
  • Table 277. North America Methyltestosterone, by Application USD Million (2019-2024)
  • Table 278. North America Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 279. United States Methyltestosterone, by Type USD Million (2019-2024)
  • Table 280. United States Methyltestosterone, by Application USD Million (2019-2024)
  • Table 281. United States Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 282. Canada Methyltestosterone, by Type USD Million (2019-2024)
  • Table 283. Canada Methyltestosterone, by Application USD Million (2019-2024)
  • Table 284. Canada Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 285. Mexico Methyltestosterone, by Type USD Million (2019-2024)
  • Table 286. Mexico Methyltestosterone, by Application USD Million (2019-2024)
  • Table 287. Mexico Methyltestosterone, by End Users USD Million (2019-2024)
  • Table 288. Methyltestosterone Sales: by Type(K Tons)
  • Table 289. Methyltestosterone Sales Capsules , by Region K Tons (2019-2024)
  • Table 290. Methyltestosterone Sales Tablets , by Region K Tons (2019-2024)
  • Table 291. Methyltestosterone Sales Powder , by Region K Tons (2019-2024)
  • Table 292. Methyltestosterone Sales: by Application(K Tons)
  • Table 293. Methyltestosterone Sales Medical {Delayed Puberty, Hypogonadism, Cryptorchidism, Erectile Dysfunction, Others} , by Region K Tons (2019-2024)
  • Table 294. Methyltestosterone Sales Non-Medical , by Region K Tons (2019-2024)
  • Table 295. Methyltestosterone Sales: by End Users(K Tons)
  • Table 296. Methyltestosterone Sales Males , by Region K Tons (2019-2024)
  • Table 297. Methyltestosterone Sales Females , by Region K Tons (2019-2024)
  • Table 298. South America Methyltestosterone Sales, by Country K Tons (2019-2024)
  • Table 299. South America Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 300. South America Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 301. South America Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 302. Brazil Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 303. Brazil Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 304. Brazil Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 305. Argentina Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 306. Argentina Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 307. Argentina Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 308. Rest of South America Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 309. Rest of South America Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 310. Rest of South America Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 311. Asia Pacific Methyltestosterone Sales, by Country K Tons (2019-2024)
  • Table 312. Asia Pacific Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 313. Asia Pacific Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 314. Asia Pacific Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 315. China Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 316. China Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 317. China Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 318. Japan Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 319. Japan Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 320. Japan Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 321. India Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 322. India Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 323. India Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 324. South Korea Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 325. South Korea Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 326. South Korea Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 327. Taiwan Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 328. Taiwan Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 329. Taiwan Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 330. Australia Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 331. Australia Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 332. Australia Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 333. Rest of Asia-Pacific Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 334. Rest of Asia-Pacific Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 335. Rest of Asia-Pacific Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 336. Europe Methyltestosterone Sales, by Country K Tons (2019-2024)
  • Table 337. Europe Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 338. Europe Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 339. Europe Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 340. Germany Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 341. Germany Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 342. Germany Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 343. France Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 344. France Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 345. France Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 346. Italy Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 347. Italy Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 348. Italy Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 349. United Kingdom Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 350. United Kingdom Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 351. United Kingdom Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 352. Netherlands Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 353. Netherlands Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 354. Netherlands Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 355. Rest of Europe Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 356. Rest of Europe Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 357. Rest of Europe Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 358. MEA Methyltestosterone Sales, by Country K Tons (2019-2024)
  • Table 359. MEA Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 360. MEA Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 361. MEA Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 362. Middle East Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 363. Middle East Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 364. Middle East Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 365. Africa Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 366. Africa Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 367. Africa Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 368. North America Methyltestosterone Sales, by Country K Tons (2019-2024)
  • Table 369. North America Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 370. North America Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 371. North America Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 372. United States Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 373. United States Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 374. United States Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 375. Canada Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 376. Canada Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 377. Canada Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 378. Mexico Methyltestosterone Sales, by Type K Tons (2019-2024)
  • Table 379. Mexico Methyltestosterone Sales, by Application K Tons (2019-2024)
  • Table 380. Mexico Methyltestosterone Sales, by End Users K Tons (2019-2024)
  • Table 381. Methyltestosterone: by Type(USD/Units)
  • Table 382. Research Programs/Design for This Report
  • Table 383. Key Data Information from Secondary Sources
  • Table 384. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Methyltestosterone: by Type USD Million (2013-2018)
  • Figure 5. Global Methyltestosterone: by Application USD Million (2013-2018)
  • Figure 6. Global Methyltestosterone: by End Users USD Million (2013-2018)
  • Figure 7. South America Methyltestosterone Share (%), by Country
  • Figure 8. Asia Pacific Methyltestosterone Share (%), by Country
  • Figure 9. Europe Methyltestosterone Share (%), by Country
  • Figure 10. MEA Methyltestosterone Share (%), by Country
  • Figure 11. North America Methyltestosterone Share (%), by Country
  • Figure 12. Global Methyltestosterone: by Type K Tons (2013-2018)
  • Figure 13. Global Methyltestosterone: by Application K Tons (2013-2018)
  • Figure 14. Global Methyltestosterone: by End Users K Tons (2013-2018)
  • Figure 15. South America Methyltestosterone Share (%), by Country
  • Figure 16. Asia Pacific Methyltestosterone Share (%), by Country
  • Figure 17. Europe Methyltestosterone Share (%), by Country
  • Figure 18. MEA Methyltestosterone Share (%), by Country
  • Figure 19. North America Methyltestosterone Share (%), by Country
  • Figure 20. Global Methyltestosterone: by Type USD/Units (2013-2018)
  • Figure 21. Global Methyltestosterone share by Players 2018 (%)
  • Figure 22. Global Methyltestosterone share by Players (Top 3) 2018(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Impax Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 25. Impax Laboratories (United States) Revenue: by Geography 2018
  • Figure 26. Bausch Health (Canada) Revenue, Net Income and Gross profit
  • Figure 27. Bausch Health (Canada) Revenue: by Geography 2018
  • Figure 28. HARBIN PHARMACEUTICAL GROUP (China) Revenue, Net Income and Gross profit
  • Figure 29. HARBIN PHARMACEUTICAL GROUP (China) Revenue: by Geography 2018
  • Figure 30. Centrix Pharmaceutical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Centrix Pharmaceutical, Inc. (United States) Revenue: by Geography 2018
  • Figure 32. Conscientia Industrial Co., Ltd (Hong Kong) Revenue, Net Income and Gross profit
  • Figure 33. Conscientia Industrial Co., Ltd (Hong Kong) Revenue: by Geography 2018
  • Figure 34. Farmabios SpA (Italy) Revenue, Net Income and Gross profit
  • Figure 35. Farmabios SpA (Italy) Revenue: by Geography 2018
  • Figure 36. AASraw Biochemical Technology Co.; Ltd (Hong Kong) Revenue, Net Income and Gross profit
  • Figure 37. AASraw Biochemical Technology Co.; Ltd (Hong Kong) Revenue: by Geography 2018
  • Figure 38. Global Methyltestosterone: by Type USD Million (2019-2024)
  • Figure 39. Global Methyltestosterone: by Application USD Million (2019-2024)
  • Figure 40. Global Methyltestosterone: by End Users USD Million (2019-2024)
  • Figure 41. South America Methyltestosterone Share (%), by Country
  • Figure 42. Asia Pacific Methyltestosterone Share (%), by Country
  • Figure 43. Europe Methyltestosterone Share (%), by Country
  • Figure 44. MEA Methyltestosterone Share (%), by Country
  • Figure 45. North America Methyltestosterone Share (%), by Country
  • Figure 46. Global Methyltestosterone: by Type K Tons (2019-2024)
  • Figure 47. Global Methyltestosterone: by Application K Tons (2019-2024)
  • Figure 48. Global Methyltestosterone: by End Users K Tons (2019-2024)
  • Figure 49. South America Methyltestosterone Share (%), by Country
  • Figure 50. Asia Pacific Methyltestosterone Share (%), by Country
  • Figure 51. Europe Methyltestosterone Share (%), by Country
  • Figure 52. MEA Methyltestosterone Share (%), by Country
  • Figure 53. North America Methyltestosterone Share (%), by Country
  • Figure 54. Global Methyltestosterone: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Impax Laboratories (United States)
  • Bausch Health (Canada)
  • HARBIN PHARMACEUTICAL GROUP (China)
  • Centrix Pharmaceutical, Inc. (United States)
  • Conscientia Industrial Co., Ltd (Hong Kong)
  • Farmabios SpA (Italy)
  • AASraw Biochemical Technology Co.; Ltd (Hong Kong)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation